These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


74 related items for PubMed ID: 3010370

  • 1. [Changes in the ratio of cyclic nucleotide phosphodiesterase forms in the thymocytes of irradiated mice].
    Rybalkin SD, Sobolev AS.
    Radiobiologiia; 1986; 26(2):167-70. PubMed ID: 3010370
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS, Rybalkin SD.
    Cell Biochem Funct; 1986 Jul; 4(3):205-11. PubMed ID: 3015450
    [Abstract] [Full Text] [Related]

  • 4. [Multiple forms of cyclic nucleotide phosphotransferases in mouse thymocytes].
    Rybalkin SD, Kurennaia GS, Sobolev AS.
    Biokhimiia; 1984 Dec; 49(12):1927-33. PubMed ID: 6098315
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and degradation of cyclic nucleotides in brain after a high dose of ionizing radiation.
    Hunt WA, Dalton TK.
    Radiat Res; 1981 Mar; 85(3):604-8. PubMed ID: 6111104
    [No Abstract] [Full Text] [Related]

  • 7. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN, Weiss B.
    Mol Pharmacol; 1979 Nov; 16(3):851-64. PubMed ID: 231197
    [No Abstract] [Full Text] [Related]

  • 8. Increased cyclic nucleotide phosphodiesterase activity associated with proliferation and cancer in human and murine lymphoid cells.
    Epstein PM, Mills JS, Ross CP, Strada SJ, Hersh EM, Thompson WJ.
    Cancer Res; 1977 Nov; 37(11):4016-23. PubMed ID: 198126
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Characteristics of the cyclic nucleotide phosphodiesterases in a transplantable pheochromocytoma and adrenal medulla of the rat.
    Levin RM, Weiss B.
    Cancer Res; 1978 Apr; 38(4):915-20. PubMed ID: 205349
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclic nucleotide phosphodiesterase in normal and leukemic human lymphocytes and lymphoblasts.
    Epstein PM, Hachisu R.
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984 Apr; 16():303-24. PubMed ID: 6202124
    [No Abstract] [Full Text] [Related]

  • 18. Activation of human lymphocyte high affinity cyclic AMP phosphodiesterase by culture with 1-methyl-3-isobutylxanthine.
    Thompson WJ, Ross CP, Hersh EM, Epstein PM, Strada SJ.
    J Cyclic Nucleotide Res; 1980 Apr; 6(1):25-36. PubMed ID: 6155390
    [Abstract] [Full Text] [Related]

  • 19. Characterization of a human melanoma cell line (KHm-1) containing phosphodiesterase activity only for cyclic adenosine 3':5'-monophosphate.
    King LE, Solomon SS, Hashimoto K.
    Cancer Res; 1978 Nov; 38(11 Pt 1):3879-85. PubMed ID: 29705
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.